"Second Opinion" with Christina Farr, Ash Zenooz MD, & Luba Greenwood JD

Second Opinion doesn't hold back. Join Christina Farr, Ash Zenooz, Luba Greenwood, as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. This season, we’re tackling meaty topics like biose...

Recent Episodes

View all
The problem with bad therapy — with Alex Katz, Two Chairs CEO
Sept. 11, 2024

The problem with bad therapy — with Alex Katz, Two Chairs CEO

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood dive into the intricacies of the behavioral health industry with Alex Katz, CEO of Two Chairs.
All the things we don’t tell women with author Leslie Schrock
Sept. 4, 2024

All the things we don’t tell women with author Leslie Schrock

In this episode of Second Opinion, Leslie Schrock, author of Bumpin' and Fertility Rules, joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss women's health.
Selling into the employer is harder than it's ever been with Included Health's Owen Tripp
Aug. 28, 2024

Selling into the employer is harder than it's ever been with Included Health's Owen Tripp

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood sit down with Owen Tripp, the CEO of Included Health. They discuss the challenges of selling digital health solutions to employers, the…
Raising from VC and PE in Health Tech with Meg FitzGerald of Grey Ghost Capital
Aug. 21, 2024

Raising from VC and PE in Health Tech with Meg FitzGerald of Grey Ghost Capital

In this episode of Second Opinion, Meg FitzGerald, a nurse turned private equity investor, offers insights into how VCs and PEs are thinking of investing in healthcare and everything founders should know to raise from both.
Big tech's healthcare hurdles with Sumit Nagpal, CEO of Cherish
Aug. 14, 2024

Big tech's healthcare hurdles with Sumit Nagpal, CEO of Cherish

In this eye-opening episode, Christina Farr and Luba Greenwood dive deep into the challenges big tech faces in healthcare with serial entrepreneur and Cherish CEO Sumit Nagpal.
Breaking down biotech with Daphne Zohar: VC dynamics, drug development, and the Biosecure Act
Aug. 7, 2024

Breaking down biotech with Daphne Zohar: VC dynamics, drug development, and the Biosecure Act

In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Daphne Zohar, CEO of Seaport Therapeutics.
View all Episodes